Effective public health measures to mitigate the spread of COVID-19: a systematic review

I Ayouni, J Maatoug, W Dhouib, N Zammit, SB Fredj… - BMC public health, 2021 - Springer
Abstract Background In December 2019, a novel coronavirus (2019-nCoV) was recognized
in Wuhan, China. It was characterised by rapid spread causing a pandemic. Multiple public …

The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri… - The Lancet, 2022 - thelancet.com
Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

Estimated transmissibility and impact of SARS-CoV-2 lineage B. 1.1. 7 in England

NG Davies, S Abbott, RC Barnard, CI Jarvis… - Science, 2021 - science.org
INTRODUCTION Several novel variants of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the virus that causes COVID-19, emerged in late 2020. One of these, Variant …

Inferring the effectiveness of government interventions against COVID-19

JM Brauner, S Mindermann, M Sharma, D Johnston… - Science, 2021 - science.org
INTRODUCTION Governments across the world have implemented a wide range of
nonpharmaceutical interventions (NPIs) to mitigate the spread of severe acute respiratory …

Non-pharmaceutical interventions during the COVID-19 pandemic: A review

N Perra - Physics Reports, 2021 - Elsevier
Infectious diseases and human behavior are intertwined. On one side, our movements and
interactions are the engines of transmission. On the other, the unfolding of viruses might …

Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study

AK Clift, CAC Coupland, RH Keogh, K Diaz-Ordaz… - bmj, 2020 - bmj.com
Objective To derive and validate a risk prediction algorithm to estimate hospital admission
and mortality outcomes from coronavirus disease 2019 (covid-19) in adults. Design …

[HTML][HTML] The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a …

Y Li, H Campbell, D Kulkarni, A Harpur… - The Lancet Infectious …, 2021 - thelancet.com
Summary Background Non-pharmaceutical interventions (NPIs) were implemented by many
countries to reduce the transmission of severe acute respiratory syndrome coronavirus 2 …

[HTML][HTML] Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical …

AJ Kucharski, P Klepac, AJK Conlan… - The Lancet infectious …, 2020 - thelancet.com
Background The isolation of symptomatic cases and tracing of contacts has been used as an
early COVID-19 containment measure in many countries, with additional physical distancing …

Vaccine optimization for COVID-19: Who to vaccinate first?

L Matrajt, J Eaton, T Leung, ER Brown - Science Advances, 2021 - science.org
Vaccines, when available, will likely become our best tool to control the COVID-19
pandemic. Even in the most optimistic scenarios, vaccine shortages will likely occur. Using …

Antibody response to SARS-CoV-2 infection in humans: A systematic review

N Post, D Eddy, C Huntley, MCI Van Schalkwyk… - PloS one, 2020 - journals.plos.org
Background Progress in characterising the humoral immune response to Severe Acute
Respiratory Syndrome 2 (SARS-CoV-2) has been rapid but areas of uncertainty persist …